"Updated PBCAR0191 Efficacy Looks Compelling" - Stifel Reiterates Buy Rating on Precision BioSciences (DTIL) with $16 Price Target
Tweet Send to a Friend
Stifel analyst Benjamin J. Burnett reiterated a Buy rating and $16.00 price target on Precision BioSciences Inc. (NASDAQ: DTIL), following ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
